GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Goodwill-to-Asset

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Goodwill-to-Asset : 0.00 (As of Sep. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Proto Script Pharmaceutical's Goodwill for the quarter that ended in Sep. 2017 was $0.00 Mil. Proto Script Pharmaceutical's Total Assets for the quarter that ended in Sep. 2017 was $0.24 Mil. Therefore, Proto Script Pharmaceutical's Goodwill to Asset Ratio for the quarter that ended in Sep. 2017 was 0.00.


Proto Script Pharmaceutical Goodwill-to-Asset Historical Data

The historical data trend for Proto Script Pharmaceutical's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Goodwill-to-Asset Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Goodwill-to-Asset
- - - - -

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Proto Script Pharmaceutical's Goodwill-to-Asset

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical's Goodwill-to-Asset Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Goodwill-to-Asset falls into.



Proto Script Pharmaceutical Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Proto Script Pharmaceutical's Goodwill to Asset Ratio for the fiscal year that ended in May. 2016 is calculated as

Goodwill to Asset (A: May. 2016 )=Goodwill/Total Assets
=0/0.012
=

Proto Script Pharmaceutical's Goodwill to Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

Goodwill to Asset (Q: Sep. 2017 )=Goodwill/Total Assets
=0/0.235
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proto Script Pharmaceutical  (OTCPK:PSCR) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Proto Script Pharmaceutical Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines